PROT# NU 08H9 - A Phase I Trial of Tamibarotene and Arsenic Trioxide for the Treatment of Relapsed Acute Promyelocytic Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date9/3/099/3/12

Funding

  • CytRx Corporation (NU 08H9)